Sustainable Growth Advisers, LP Novo Nordisk A S Transaction History

Sustainable Growth Advisers, LP

  • $22.1 Billion
  • Q1 2024

A detailed history of Sustainable Growth Advisers, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Sustainable Growth Advisers, LP holds 3,808,462 shares of NVO stock, worth $515 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares
3,808,462
Previous 4,005,277 4.91%
Holding current value
$515 Million
Previous $414 Million 18.02%
% of portfolio
2.21%
Previous 2.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$102.11 - $135.92 $20.1 Million - $26.8 Million
-196,815 Reduced 4.91%
3,808,462 $489 Million
Q4 2023

Feb 06, 2024
BUY
$87.78 - $105.45 $332 Million - $398 Million
3,778,100 Added 1663.06%
4,005,277 $414 Million
Q3 2023

Nov 09, 2023
BUY
$90.94 - $199.54 $10.6 Million - $23.2 Million
116,356 Added 104.99%
227,177 $20.7 Million
Q2 2023

Aug 08, 2023
BUY
$155.98 - $172.65 $4.1 Million - $4.53 Million
26,257 Added 31.05%
110,821 $17.9 Million
Q1 2023

May 09, 2023
SELL
$132.34 - $159.14 $2.49 Million - $2.99 Million
-18,792 Reduced 18.18%
84,564 $13.5 Million
Q4 2022

May 12, 2023
BUY
$102.55 - $135.33 $1.93 Million - $2.54 Million
18,792 Added 22.22%
103,356 $14 Million
Q4 2022

Jan 30, 2023
SELL
$102.55 - $135.33 $1.95 Million - $2.57 Million
-19,016 Reduced 15.54%
103,356 $14 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $2.96 Million - $3.64 Million
-31,100 Reduced 20.26%
122,372 $12.2 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $3.5 Million - $4.13 Million
-33,881 Reduced 18.08%
153,472 $17.1 Million
Q1 2022

May 10, 2022
BUY
$93.1 - $112.54 $1.95 Million - $2.36 Million
20,947 Added 12.59%
187,353 $20.8 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $3.2 Million - $3.9 Million
-33,345 Reduced 16.69%
166,406 $18.6 Million
Q3 2021

Nov 10, 2021
SELL
$84.42 - $106.62 $3.21 Million - $4.05 Million
-37,992 Reduced 15.98%
199,751 $19.2 Million
Q2 2021

Aug 10, 2021
BUY
$67.66 - $84.76 $113,736 - $142,481
1,681 Added 0.71%
237,743 $19.9 Million
Q1 2021

May 10, 2021
BUY
$67.06 - $75.82 $4.01 Million - $4.53 Million
59,747 Added 33.89%
236,062 $15.9 Million
Q4 2020

Feb 04, 2021
SELL
$63.89 - $73.8 $736,332 - $850,545
-11,525 Reduced 6.14%
176,315 $12.3 Million
Q3 2020

Nov 10, 2020
SELL
$63.69 - $70.22 $9.54 Million - $10.5 Million
-149,790 Reduced 44.37%
187,840 $13 Million
Q2 2020

Aug 10, 2020
SELL
$58.54 - $67.94 $646,047 - $749,785
-11,036 Reduced 3.17%
337,630 $22.1 Million
Q1 2020

May 07, 2020
SELL
$49.46 - $64.78 $112 Million - $147 Million
-2,263,361 Reduced 86.65%
348,666 $21 Million
Q4 2019

Feb 04, 2020
SELL
$49.86 - $58.26 $58.3 Million - $68.1 Million
-1,168,504 Reduced 30.91%
2,612,027 $151 Million
Q3 2019

Nov 13, 2019
BUY
$47.54 - $53.43 $7.27 Million - $8.17 Million
152,916 Added 4.22%
3,780,531 $195 Million
Q2 2019

Aug 12, 2019
BUY
$46.79 - $52.47 $4.18 Million - $4.69 Million
89,413 Added 2.53%
3,627,615 $185 Million
Q1 2019

May 10, 2019
SELL
$46.36 - $52.63 $3.43 Million - $3.9 Million
-74,043 Reduced 2.05%
3,538,202 $185 Million
Q4 2018

Feb 06, 2019
SELL
$41.54 - $47.25 $7.42 Million - $8.44 Million
-178,683 Reduced 4.71%
3,612,245 $166 Million
Q3 2018

Nov 07, 2018
SELL
$46.76 - $51.24 $1.72 Million - $1.89 Million
-36,810 Reduced 0.96%
3,790,928 $179 Million
Q2 2018

Aug 10, 2018
SELL
$44.29 - $50.42 $4.88 Million - $5.55 Million
-110,155 Reduced 2.8%
3,827,738 $177 Million
Q1 2018

May 09, 2018
BUY
$48.49 - $58.14 $6.09 Million - $7.3 Million
125,614 Added 3.29%
3,937,893 $194 Million
Q4 2017

Feb 13, 2018
BUY
$47.53 - $53.73 $14 Million - $15.8 Million
293,732 Added 8.35%
3,812,279 $205 Million
Q3 2017

Nov 13, 2017
BUY
$41.15 - $49.22 $145 Million - $173 Million
3,518,547
3,518,547 $169 Million

Others Institutions Holding NVO

# of Institutions
1,851
Shares Held
309M
Call Options Held
5.29M
Put Options Held
4.93M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sustainable Growth Advisers, LP Portfolio

Follow Sustainable Growth Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sustainable Growth Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sustainable Growth Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email